Pacing for hypertrophic obstructive cardiomyopathy: an update and future directions.

about

Cardiac pacing in patients with hypertrophic obstructive cardiomyopathy

P2860

Q58565552-5794108F-6B10-4BDC-B134-11A89049034C

P2860

Pacing for hypertrophic obstructive cardiomyopathy: an update and future directions.

Item

http://www.wikidata.org/entity/Q47857686

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Pacing for hypertrophic obstructive cardiomyopathy: an update and future directions.

@en

Pacing for hypertrophic obstructive cardiomyopathy: an update and future directions.

@nl

type

Item

label

Pacing for hypertrophic obstructive cardiomyopathy: an update and future directions.

@en

Pacing for hypertrophic obstructive cardiomyopathy: an update and future directions.

@nl

prefLabel

Pacing for hypertrophic obstructive cardiomyopathy: an update and future directions.

@en

Pacing for hypertrophic obstructive cardiomyopathy: an update and future directions.

@nl

P1476

Pacing for hypertrophic obstructive cardiomyopathy: an update and future directions.

@en

P2093

Claude Daubert

http://www.w3.org/2001/XMLSchema#string

Fredrik Gadler

http://www.w3.org/2001/XMLSchema#string

Philippe Mabo

http://www.w3.org/2001/XMLSchema#string

P2860

Pharmacological treatment options for hypertrophic cardiomyopathy: high time for evidence

Outcome and complications after implantable cardioverter defibrillator therapy in hypertrophic cardiomyopathy: systematic review and meta-analysis

Significant improvement of quality of life following atrioventricular synchronous pacing in patients with hypertrophic obstructive cardiomyopathy. Data from 1 year of follow-up. PIC study group. Pacing In Cardiomyopathy.

Symptomatic hypertrophic obstructive cardiomyopathy: the role of dual-chamber pacing.

Impact of dual-chamber permanent pacing in patients with obstructive hypertrophic cardiomyopathy with symptoms refractory to verapamil and beta-adrenergic blocker therapy.

Long-term outcome of percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: a Scandinavian multicenter study.

A validation study of the 2003 American College of Cardiology/European Society of Cardiology and 2011 American College of Cardiology Foundation/American Heart Association risk stratification and treatment algorithms for sudden cardiac death in patie

A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD).

2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC).

Hypertrophic obstructive cardiomyopathy.

P31

scholarly article

P356

10.1093/EUROPACE/EUX131

http://www.w3.org/2001/XMLSchema#string

P50

Cecilia Linde

P577

2017-06-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29106577

http://www.w3.org/2001/XMLSchema#string

P921

hypertrophic obstructive cardiomyopathy

Pacing for hypertrophic obstructive cardiomyopathy: an update and future directions.

about

P2860

P2860

Pacing for hypertrophic obstructive cardiomyopathy: an update and future directions.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P31

P356

P50

P577

P698

P921